NasoNeb® is a global developer and manufacturer of intranasal drug delivery systems, with a focus on helping people feel better and breathe better. Established in 2009, the company is dedicated to breaking down barriers to wellness and has gained recognition for its flagship product, the NasoNeb® Sinus Therapy System. This powered nasal nebulizer delivers high concentrations of medication to provide fast and efficient relief for sinus and rhinitis patients.
The company's commitment to working with physicians, hospitals, and patients to improve wellness is evident in its mission. Additionally, the NasoNeb® Sinus Therapy System allows users to select the solution they want to deliver to their nasal cavities and offers unmatched, powered aerosol coverage that traditional methods cannot provide.
As a division of Monaghan Medical Corporation, NasoNeb® NDS is based in Plattsburgh, NY, USA. Monaghan Medical is a global leader in the development and manufacturing of innovative, high-quality, patient-oriented aerosol drug delivery devices and respiratory management products. With a state-of-the-art aerosol research laboratory, the company aims to provide the most advanced, therapeutic, and cost-effective solutions to patients, caregivers, and pharmaceutical companies worldwide.